| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5733886 | BAUSCH | Compositions of clindamycin and benzoyl peroxide for acne treatment |
Mar, 2015
(9 years ago) | |
| US10220049 | BAUSCH | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent |
Jun, 2029
(5 years from now) | |
| US8895070 | BAUSCH | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent |
Jun, 2029
(5 years from now) | |
| US8663699 | BAUSCH | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent |
Jun, 2029
(5 years from now) | |
| US9078870 | BAUSCH | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent |
Jun, 2029
(5 years from now) | |
| US10624918 | BAUSCH | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent |
Jun, 2029
(5 years from now) | |
| US8288434 | BAUSCH | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent |
Aug, 2029
(5 years from now) | |
Acanya is owned by Bausch.
Acanya contains Benzoyl Peroxide; Clindamycin Phosphate.
Acanya has a total of 7 drug patents out of which 1 drug patent has expired.
Expired drug patents of Acanya are:
- US5733886
Acanya was authorised for market use on 24 November, 2014.
Acanya is available in gel;topical dosage forms.
Acanya can be used as topical treatment of acne vulgaris in patients 12 years or older, treatment of acne.
The generics of Acanya are possible to be released after 05 August, 2029.
Drugs and Companies using BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE ingredient
Market Authorisation Date: 24 November, 2014
Treatment: Topical treatment of acne vulgaris in patients 12 years or older; Treatment of acne
Dosage: GEL;TOPICAL
ACANYA family patents
